Insider Transactions in Q3 2021 at Candel Therapeutics, Inc. (CADL)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2021
|
Nathan Caffo Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$48,000
$8.0 P/Share
|
|
Jul 29
2021
|
Laura K. Aguilar > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
56,096
+5.68%
|
-
|
|
Jul 29
2021
|
John J Canepa Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,125
+50.0%
|
$81,000
$8.0 P/Share
|
|
Jul 29
2021
|
Paul B Manning |
BUY
Conversion of derivative security
|
Indirect |
1,232,910
+50.0%
|
-
|
|
Jul 29
2021
|
Paul Peter Tak Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
25,000
+50.0%
|
$200,000
$8.0 P/Share
|
|
Jul 29
2021
|
Diem Nguyen |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$80,000
$8.0 P/Share
|
|
Jul 29
2021
|
Estuardo Aguilar Cordova > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
162,137
+13.76%
|
-
|
|
Jul 29
2021
|
Christopher Martell |
BUY
Open market or private purchase
|
Indirect |
125,000
+50.0%
|
$1,000,000
$8.0 P/Share
|
|
Jul 29
2021
|
Christopher Martell |
BUY
Conversion of derivative security
|
Indirect |
283,514
+50.0%
|
-
|
|
Jul 29
2021
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
20,000
+26.32%
|
$140,000
$7.3 P/Share
|
|
Jul 27
2021
|
Paul B Manning |
BUY
Open market or private purchase
|
Direct |
36,000
+50.0%
|
$252,000
$7.36 P/Share
|